ABSTRACT SUBMISSION SITE NOW OPEN
Submission Date Extended until October 24
ABSTRACTS
The NASPAG Program Committee invites you to submit abstracts pertinent to the field of pediatric and adolescent gynecology for presentation at the 37th Annual Clinical Research Meeting (ACRM). Abstracts describing original research or case reports/series will be considered.
September 12 - Abstract Site Opens
October 24 (11:59 PM ET) - Abstract Site Closes
2023 ACRM ABSTRACT GUIDELINES AND SUBMISSION SITE
REGISTRATION
Registration will open in November 2022
Talking points - COVID-19 Vaccine and Reproductive Health:
With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.
NASPAG'S Response to Texas Senate Bill 8
NASPAG’s mission is to advocate for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased, and evidence-based practice of Pediatric and Adolescent Gynecology. The Texas Senate Bill 8 undermines the ability of Pediatric and Adolescent health care providers to align with NASPAG’s mission. This bill impacts critical reproductive health care, which undoubtedly will disproportionately impact those with poorest resources and access to care. This is one of the most restrictive abortions bans in the US, making abortion illegal with no exceptions for rape, sexual abuse, incest, or fetal anomaly diagnosis.
